semaglutide fatty liver Gets FDA Greenlight for MASH semaglutide nash Pharmacological Therapeutics: Current

Federal regulators have given the green light to a new GLP-1 weight loss tablet that people can take with or without food

An inducible Clec7a-CreERT2 mouse line enables selective genetic tracing of proliferative-region-associated microglia (PAM) and DAM in the CNS ( in vivo tracing demonstrated state transitions, exhibiting reversible microglial plasticity

the company has also recently acquired obesity drug developer Metsera, along with another experimental GLP-1 drug

Bring your log, labels, and timeline to appointments instead of screenshots alone

Simonetti, MD Resources for Our Patients Meet the Team Our comprehensive weight management team is here to help you successfully lose weight and support you in your weight loss journey